POLR2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.26759996838177E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.30919999999468E-05 |
Normal-vs-Stage2 |
2.00149999999288E-05 |
Normal-vs-Stage3 |
1.3183999447719E-09 |
Normal-vs-Stage4 |
1.46520018340368E-10 |
Stage1-vs-Stage2 |
1.285620E-01 |
Stage1-vs-Stage3 |
1.821120E-03 |
Stage1-vs-Stage4 |
1.984580E-04 |
Stage2-vs-Stage3 |
4.728400E-01 |
Stage2-vs-Stage4 |
1.583000E-01 |
Stage3-vs-Stage4 |
3.641400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.81849998895467E-09 |
Normal-vs-AfricanAmerican |
1.19890000005451E-06 |
Normal-vs-Asian |
5.605200E-01 |
Caucasian-vs-AfricanAmerican |
3.866400E-01 |
Caucasian-vs-Asian |
7.123000E-03 |
AfricanAmerican-vs-Asian |
7.636300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.04820005400563E-09 |
Normal-vs-Female |
1.11629999999252E-06 |
Male-vs-Female |
5.575600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.444400E-04 |
Normal-vs-Age(41-60Yrs) |
4.91760000054242E-07 |
Normal-vs-Age(61-80Yrs) |
6.99960001071531E-09 |
Normal-vs-Age(81-100Yrs) |
7.98330000000291E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.928400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.459800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.106600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.478220E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.388580E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.997800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.255800E-01 |
Normal-vs-Grade 2 |
2.96160000001766E-06 |
Normal-vs-Grade 3 |
6.11239947545528E-11 |
Normal-vs-Grade 4 |
3.65230001797556E-09 |
Grade 1-vs-Grade 2 |
4.575600E-04 |
Grade 1-vs-Grade 3 |
3.01390000001511E-06 |
Grade 1-vs-Grade 4 |
1.95999000000002E-05 |
Grade 2-vs-Grade 3 |
3.922700E-03 |
Grade 2-vs-Grade 4 |
3.076200E-03 |
Grade 3-vs-Grade 4 |
3.539800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.819400E-04 |
Normal-vs-ccB subtype |
1.14450005028743E-09 |
ccA subtype-vs-ccB subtype |
6.29709999999672E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.98930000250286E-08 |
Normal-vs-N1 |
2.701200E-03 |
N0-vs-N1 |
7.591200E-01 |
|
|